GrowGeneration Hits an Inflection: Positive EBITDA, 40% Proprietary Brands, and a Stock That's Awake
The hydroponics retailer's pivot to a commercial B2B brand-driven model is paying off, with revenue growth, margin expansion, and a tariff refund tailwind.
GRWG · Earnings Call · 2026-08-11
A Milestone Quarter
GrowGeneration's second-quarter 2026 results mark a clear turning point in the company's multi-year restructuring. The company delivered its third consecutive quarter of year-over-year revenue growth, gross margin improved to 28.5%, and—most importantly—it returned to positive adjusted EBITDA for the first time since the cannabis industry downturn began. CFO Gregory Sanders summed it up: “We delivered our third consecutive quarter of year over year growth continued expansion of proprietary brand penetration, delivered positive adjusted EBITDA and maintained the disciplined cost structure that we have built over the past several years.” — Gregory Sanders, Chief Financial Officer · 2026-08-11 The company is so confident in the trajectory that it raised full-year 2026 adjusted EBITDA guidance to $2–$3 million from roughly breakeven, while reaffirming revenue guidance of $162–$168 million. The driver of this momentum is a deliberate strategic pivot. CEO Darren Lampert emphasized: “Our expanded commercial B2B business is a core growth driver of our strategy.” — Darren Lampert, Co-Founder and Chief Executive Officer · 2026-08-11 This is not just talk—commercial B2B business revenue has been the engine, with the cultivation and gardening segment growing to $34.9 million from $32.9 million a year ago, even as the retail store footprint shrinks.Proprietary Brands: Ahead of Schedule
The most striking metric in the quarter is the penetration of proprietary brands. Management set a year-end target of 40% of cultivation and gardening revenue from proprietary brands, and it hit that already in Q2. Proprietary brand sales reached 39.7% of cultivation revenue, up from 32% in the prior-year quarter. This is not a fluke—the company has been building this muscle for years. In the Q&A, Darren noted: “I think we have been pretty transparent that our commercial business, our MSO business is certainly expanding. We still do believe that we are in the early stages of growth in a bunch of our proprietary brands that are out on the market right now.” — Darren Lampert, Co-Founder and Chief Executive Officer · 2026-08-11 The Proprietary brand story is central to margin expansion; these products carry higher margins and create a recurring consumable revenue stream. The company expects this mix to continue to improve, and management believes they are just at the start of private-label penetration in the hydroponic space.Balance Sheet Strength and Capital Allocation
GrowGeneration ended the quarter with $41 million in cash and no debt, a disciplined cost structure that has cut operating expenses by 22% year-over-year, and a $10 million share repurchase program in motion. During Q2, the company repurchased 700,000 shares at an average price of $1.38. The buyback reflects management's view that the stock is undervalued relative to its balance sheet and growth prospects. In the prior quarter, Darren explained the rationale: “We are trading at about a $60 million market cap with about $85 million of cash and inventory, and some tremendous assets within our company.” — Darren Lampert, Co-Founder and Chief Executive Officer · 2026-03-19 That valuation gap has narrowed somewhat given the recent rally, but the company continues to execute its buyback opportunistically.Tariff Refund and Rescheduling Tailwinds
A significant near-term catalyst is the expected recognition of IEEPA tariff refunds. CFO Gregory Sanders stated: “we are expecting an IEPA tariff amount to be recognized in the third quarter that exceeds $2 million” — Gregory Sanders, Chief Financial Officer · 2026-08-11. This is a direct injection to EBITDA and explains some of the guidance increase. The company has been navigating tariff headwinds for over a year, and this refund is a concrete benefit from the ongoing trade policy saga. Additionally, the company continues to monitor the federal cannabis rescheduling process. Darren highlighted: "Since our last earnings call, the ALJ concluded its formal hearings While a ruling is still pending, we are confident that regardless of timing, GrowGen is well positioned to support increased investment activity from our customers." This is a recurring theme—the company has been positioning for a rescheduling-driven capex cycle, and the recent 90-day stock surge (+65%) suggests the market is starting to believe.Fundamentals and Market Reaction
The financial metrics confirm the turnaround. While Total Revenue remains well below the 2021 peak, the sequential and year-over-year growth is encouraging. The gross margin improvement to 28.5% is a key driver, though the company still has a way to go to reach its 30% target. The balance sheet is robust, and the company has effectively no leverage. The stock's recent performance is a reflection of the improving narrative: the 90-day tape shows a +65% rally, with the stock touching $1.89 in mid-August. However, this comes after a -97% drawdown from the 2021 peak, so there is massive room for recovery if the strategy continues to deliver.The Path Forward
GrowGeneration's transformation is real, and the numbers are starting to confirm it. The company is on track to deliver its first full-year positive adjusted EBITDA, and the proprietary brand mix is hitting targets ahead of plan. The tariff refund and potential rescheduling provide further optionality. As Darren put it:For investors, the key question is whether this momentum can be sustained. With a strong balance sheet, a clear strategic focus, and a tailwind from refunds and regulatory changes, the risk/reward is increasingly compelling.As you can see from this quarter's performance, our strategy is continuing to drive improved financial and operating results. We look forward to keeping you updated as we make further progress during the balance of the year.